Bastajet Tablet 10/40 mg

Adult dosage

This medication is administered once daily, regardless of meals. The dosage range is 10/10 mg to 10/40 mg per day. A starting dose of either 10/10 mg or 10/20 mg per day is recommended. For patients requiring further reduction in LDL cholesterol, the dose may be adjusted. After initiating treatment or adjusting the dosage, lipid levels in the blood should be checked at intervals of more than 2 weeks before making further adjustments.

This medication can rarely cause damage to muscle tissue, leading to severe myopathy and renal dysfunction, so if muscle pain or weakness occurs, it is important to inform a physician immediately. Additionally, this medication can affect liver function, so liver function tests should be conducted before administration and liver function should be regularly monitored during treatment. Patients with an allergy to any component of this drug, those with active liver disease, muscle disease, pregnant women, or breastfeeding mothers should not take this medication. Particularly, patients with a history of liver disease, excessive alcohol consumption, elderly patients, or those with poor renal function should be more cautious when using this medication. This drug can interact with other medications, so if you are taking other drugs, you must inform your doctor or pharmacist, and dosage adjustments or cessation of administration may be necessary when used in conjunction with certain antibiotics, antivirals, and immunosuppressants. Be cautious as dizziness may occur when driving or operating machinery, and women of childbearing age should use appropriate contraceptive methods while taking this medication. If symptoms such as muscle pain, muscle weakness, fatigue, fever, etc., occur during the course of this medication, it is essential to inform healthcare professionals immediately, and if liver dysfunction or severe skin reactions are suspected, the administration should be stopped, and a medical facility should be visited. Safety and efficacy in children have not been established, so it is advisable not to administer it to them. In case of overdose, since there is no specific antidote, appropriate treatment and supportive care should be administered based on the symptoms, and liver function and muscle enzyme levels should be monitored. Finally, this medication should be stored out of the reach of children and should not be transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, peeling skin, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attack, breathing abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), severe lethargy, sudden and severe headaches, thunderclap headache, seizures, confusion, vision abnormalities, paralysis, urination changes

Mild side effects

• Fatigue
• chest pain
• chest discomfort
• edema
• asthenia
• generalized edema
• sensory impairment
• paresthesia
• hypertension
• increased ALT

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. Additionally, it is important to maintain a room temperature between 1°C and 30°C when storing the medication. Doing so will help preserve the effectiveness of the medication for a longer period.

Appearance

White oval film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTPX3)]